BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Thompson NW. Current concepts in the surgical management of multiple endocrine neoplasia type 1 pancreatic-duodenal disease. Results in the treatment of 40 patients with Zollinger-Ellison syndrome, hypoglycaemia or both. J Intern Med. 1998;243:495-500. [PMID: 9681848 DOI: 10.1046/j.1365-2796.1998.00307.x] [Cited by in Crossref: 128] [Cited by in F6Publishing: 93] [Article Influence: 5.6] [Reference Citation Analysis]
Number Citing Articles
1 Dickson PV, Rich TA, Xing Y, Cote GJ, Wang H, Perrier ND, Evans DB, Lee JE, Grubbs EG. Achieving eugastrinemia in MEN1 patients: both duodenal inspection and formal lymph node dissection are important. Surgery. 2011;150:1143-1152. [PMID: 22136834 DOI: 10.1016/j.surg.2011.09.028] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
2 Triponez F, Dosseh D, Goudet P, Cougard P, Bauters C, Murat A, Cadiot G, Niccoli-Sire P, Chayvialle JA, Calender A. Epidemiology data on 108 MEN 1 patients from the GTE with isolated nonfunctioning tumors of the pancreas. Ann Surg. 2006;243:265-272. [PMID: 16432361 DOI: 10.1097/01.sla.0000197715.96762.68] [Cited by in Crossref: 170] [Cited by in F6Publishing: 143] [Article Influence: 11.3] [Reference Citation Analysis]
3 Krampitz GW, Norton JA. Pancreatic neuroendocrine tumors. Curr Probl Surg. 2013;50:509-545. [PMID: 24206780 DOI: 10.1067/j.cpsurg.2013.08.001] [Cited by in Crossref: 36] [Cited by in F6Publishing: 26] [Article Influence: 5.1] [Reference Citation Analysis]
4 Plöckinger U, Wiedenmann B. Endocrine tumours of the gastrointestinal tract. Management of metastatic endocrine tumours. Best Pract Res Clin Gastroenterol 2005;19:553-76. [PMID: 16183527 DOI: 10.1016/j.bpg.2005.02.013] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
5 van Beek DJ, Vorselaars WMCM, Borel Rinkes IHM, Vriens MR. ASO Author Reflections: Severe Morbidity After Major Surgery in Patients with MEN1. Ann Surg Oncol 2021;28:4400-1. [PMID: 33506308 DOI: 10.1245/s10434-020-09540-0] [Reference Citation Analysis]
6 Tonelli F, Giudici F, Giusti F, Brandi ML. Gastroenteropancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1. Cancers (Basel) 2012;4:504-22. [PMID: 24213321 DOI: 10.3390/cancers4020504] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
7 Alexakis N, Neoptolemos JP. Pancreatic neuroendocrine tumours. Best Pract Res Clin Gastroenterol. 2008;22:183-205. [PMID: 18206821 DOI: 10.1016/j.bpg.2007.10.008] [Cited by in Crossref: 36] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
8 Pieterman CRC, Conemans EB, Dreijerink KMA, de Laat JM, Timmers HTM, Vriens MR, Valk GD. Thoracic and duodenopancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: natural history and function of menin in tumorigenesis. Endocrine-Related Cancer 2014;21:R121-42. [DOI: 10.1530/erc-13-0482] [Cited by in Crossref: 51] [Cited by in F6Publishing: 21] [Article Influence: 7.3] [Reference Citation Analysis]
9 Chambers AJ, Pasieka JL. Gastrinoma. Cancer Treat Res 2010;153:213-33. [PMID: 19957227 DOI: 10.1007/978-1-4419-0857-5_12] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
10 Goudet P, Calender A, Cougard P, Murat A, Henry JF, Kraimps JL, Cadiot G, Peix JL, Sarfati E, Mignon M, Proye C; Groupe d'Etude des neoplasies Endocrinienne multiples. [Multiple endocrine neoplasia type I or Werner syndrome. What is important to know about surgery of a rate disease]. Ann Chir 2002;127:591-9. [PMID: 12491633 DOI: 10.1016/s0003-3944(02)00848-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
11 Bartsch DK, Langer P, Wild A, Schilling T, Celik I, Rothmund M, Nies C. Pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1: surgery or surveillance? Surgery. 2000;128:958-966. [PMID: 11114630 DOI: 10.1067/msy.2000.109727] [Cited by in Crossref: 101] [Cited by in F6Publishing: 90] [Article Influence: 5.1] [Reference Citation Analysis]
12 Fendrich V, Langer P, Celik I, Bartsch DK, Zielke A, Ramaswamy A, Rothmund M. An aggressive surgical approach leads to long-term survival in patients with pancreatic endocrine tumors. Ann Surg. 2006;244:845-851; discussion 852-853. [PMID: 17122609 DOI: 10.1097/01.sla.0000246951.21252.60] [Cited by in Crossref: 114] [Cited by in F6Publishing: 92] [Article Influence: 8.1] [Reference Citation Analysis]
13 Ito T, Igarashi H, Uehara H, Berna MJ, Jensen RT. Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors. Medicine (Baltimore) 2013;92:135-81. [PMID: 23645327 DOI: 10.1097/MD.0b013e3182954af1] [Cited by in Crossref: 111] [Cited by in F6Publishing: 54] [Article Influence: 13.9] [Reference Citation Analysis]
14 Akerström G, Stålberg P. Surgical management of MEN-1 and -2: state of the art. Surg Clin North Am 2009;89:1047-68. [PMID: 19836484 DOI: 10.1016/j.suc.2009.06.016] [Cited by in Crossref: 29] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
15 Bartsch DK, Albers MB. Controversies in surgery for multiple endocrine neoplasia type 1-associated Zollinger–Ellison syndrome. International Journal of Endocrine Oncology 2015;2:263-71. [DOI: 10.2217/ije.15.17] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
16 Mittendorf EA, Shifrin AL, Inabnet WB, Libutti SK, Mchenry CR, Demeure MJ. Islet Cell Tumors. Current Problems in Surgery 2006;43:685-765. [DOI: 10.1067/j.cpsurg.2006.07.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
17 Machado MC. Surgical treatment of pancreatic endocrine tumors in multiple endocrine neoplasia type 1. Clinics (Sao Paulo) 2012;67 Suppl 1:145-8. [PMID: 22584720 DOI: 10.6061/clinics/2012(sup01)24] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
18 Frilling A, Akerström G, Falconi M, Pavel M, Ramos J, Kidd M, Modlin IM. Neuroendocrine tumor disease: an evolving landscape. Endocr Relat Cancer. 2012;19:R163-R185. [PMID: 22645227 DOI: 10.1530/erc-12-0024] [Cited by in Crossref: 82] [Cited by in F6Publishing: 46] [Article Influence: 9.1] [Reference Citation Analysis]
19 Tonelli F, Fratini G, Nesi G, Tommasi MS, Batignani G, Falchetti A, Brandi ML. Pancreatectomy in multiple endocrine neoplasia type 1-related gastrinomas and pancreatic endocrine neoplasias. Ann Surg. 2006;244:61-70. [PMID: 16794390 DOI: 10.1097/01.sla.0000218073.77254.62] [Cited by in Crossref: 102] [Cited by in F6Publishing: 73] [Article Influence: 6.8] [Reference Citation Analysis]
20 Grobmyer SR, Hochwald SN. Reoperative Surgery for the Zollinger-Ellison Syndrome. Advances in Surgery 2010;44:327-46. [DOI: 10.1016/j.yasu.2010.05.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
21 Fendrich V, Bartsch DK, Langer P, Zielke A, Rothmund M. [Zollinger-Ellison syndrome]. Chirurg 2005;76:217-26. [PMID: 15688179 DOI: 10.1007/s00104-004-0995-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
22 Jensen RT, Berna MJ, Bingham DB, Norton JA. Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies. Cancer 2008;113:1807-43. [PMID: 18798544 DOI: 10.1002/cncr.23648] [Cited by in Crossref: 286] [Cited by in F6Publishing: 226] [Article Influence: 22.0] [Reference Citation Analysis]
23 Mullan MH, Gauger PG, Thompson NW. Endocrine tumours of the pancreas: review and recent advances. ANZ J Surg. 2001;71:475-482. [PMID: 11504292 DOI: 10.1046/j.1440-1622.2001.02191.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 1.8] [Reference Citation Analysis]
24 Davì MV, Boninsegna L, Dalle Carbonare L, Toaiari M, Capelli P, Scarpa A, Francia G, Falconi M. Presentation and outcome of pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1 syndrome. Neuroendocrinology 2011;94:58-65. [PMID: 21464564 DOI: 10.1159/000326164] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
25 Hori T, Takaori K, Uemoto S. Pancreatic neuroendocrine tumor accompanied with multiple liver metastases. World J Hepatol 2014; 6(8): 596-600 [PMID: 25232452 DOI: 10.4254/wjh.v6.i8.596] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
26 Dreijerink KM, Höppener JW, Timmers HM, Lips CJ. Mechanisms of disease: multiple endocrine neoplasia type 1-relation to chromatin modifications and transcription regulation. Nat Clin Pract Endocrinol Metab 2006;2:562-70. [PMID: 17024155 DOI: 10.1038/ncpendmet0292] [Cited by in Crossref: 42] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
27 Mortellaro VE, Hochwald SN, Mcguigan JE, Copeland EM, Vogel SB, Grobmyer SR. Long-Term Results of a Selective Surgical Approach to Management of Zollinger-Ellison Syndrome in Patients with MEN-1. The American Surgeon 2009;75:730-3. [DOI: 10.1177/000313480907500818] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
28 Giudici F, Nesi G, Brandi ML, Tonelli F. Surgical management of insulinomas in multiple endocrine neoplasia type 1. Pancreas 2012;41:547-53. [PMID: 22228047 DOI: 10.1097/MPA.0b013e3182374e08] [Cited by in Crossref: 33] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
29 Gauger PG, Doherty GM, Broome JT, Miller BS, Thompson NW. Completion pancreatectomy and duodenectomy for recurrent MEN-1 pancreaticoduodenal endocrine neoplasms. Surgery 2009;146:801-8. [DOI: 10.1016/j.surg.2009.06.038] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
30 Glascock MJ, Carty SE. Multiple endocrine neoplasia type 1: fresh perspective on clinical features and penetrance. Surg Oncol. 2002;11:143-150. [PMID: 12356510 DOI: 10.1016/s0960-7404(01)00031-7] [Cited by in Crossref: 37] [Cited by in F6Publishing: 7] [Article Influence: 2.1] [Reference Citation Analysis]
31 Imamura M. Recent standardization of treatment strategy for pancreatic neuroendocrine tumors. World J Gastroenterol 2010; 16(36): 4519-4525 [PMID: 20857521 DOI: 10.3748/wjg.v16.i36.4519] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 31] [Article Influence: 3.0] [Reference Citation Analysis]
32 Gibril F, Jensen R. Diagnostic uses of radiolabelled somatostatin receptor analogues in gastroenteropancreatic endocrine tumours. Digestive and Liver Disease 2004;36:S106-20. [DOI: 10.1016/j.dld.2003.11.024] [Cited by in Crossref: 81] [Cited by in F6Publishing: 64] [Article Influence: 4.8] [Reference Citation Analysis]
33 Vidal A, Iglesias M, Fernández B, Fonseca E, Cordido F. Cutaneous lesions associated to multiple endocrine neoplasia syndrome type 1. J Eur Acad Dermatol Venerol 2008;22:835-8. [DOI: 10.1111/j.1468-3083.2008.02578.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
34 Alexakis N, Connor S, Ghaneh P, Lombard M, Smart H, Evans J, Hughes M, Garvey C, Vora J, Vinjamuri S, Sutton R, Neoptolemos J, Dralle H. Hereditary pancreatic endocrine tumours. Pancreatology 2004;4:417-35. [DOI: 10.1159/000079616] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 2.9] [Reference Citation Analysis]
35 Tonelli F, Giudici F, Fratini G, Brandi ML. Pancreatic endocrine tumors in multiple endocrine neoplasia type 1 syndrome: review of literature. Endocr Pract. 2011;17 Suppl 3:33-40. [PMID: 21550956 DOI: 10.4158/ep10376.ra] [Cited by in Crossref: 29] [Cited by in F6Publishing: 11] [Article Influence: 3.2] [Reference Citation Analysis]
36 Gimm O. Familial Endocrine Conditions. In: Hubbard J, Inabnet WB, Lo C, editors. Endocrine Surgery. London: Springer; 2009. pp. 567-81. [DOI: 10.1007/978-1-84628-881-4_43] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
37 Pieterman CRC, Vriens MR, Dreijerink KMA, van der Luijt RB, Valk GD. Care for patients with multiple endocrine neoplasia type 1: the current evidence base. Familial Cancer 2011;10:157-71. [DOI: 10.1007/s10689-010-9398-6] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
38 Selberherr A, Koperek O, Riss P, Scheuba C, Niederle MB, Kaderli R, Perren A, Niederle B. Intertumor heterogeneity in 60 pancreatic neuroendocrine tumors associated with multiple endocrine neoplasia type 1. Orphanet J Rare Dis 2019;14:54. [PMID: 30795813 DOI: 10.1186/s13023-019-1034-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
39 Fendrich V, Waldmann J, Bartsch DK, Langer P. Surgical management of pancreatic endocrine tumors. Nat Rev Clin Oncol 2009;6:419-28. [DOI: 10.1038/nrclinonc.2009.82] [Cited by in Crossref: 81] [Cited by in F6Publishing: 62] [Article Influence: 6.8] [Reference Citation Analysis]
40 Norton JA, Jensen RT. Role of surgery in Zollinger-Ellison syndrome. J Am Coll Surg. 2007;205:S34-S37. [PMID: 17916516 DOI: 10.1016/j.jamcollsurg.2007.06.320] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 2.4] [Reference Citation Analysis]
41 Waldmann J, Fendrich V, Habbe N, Bartsch DK, Slater EP, Kann PH, Rothmund M, Langer P. Screening of patients with multiple endocrine neoplasia type 1 (MEN-1): a critical analysis of its value. World J Surg 2009;33:1208-18. [PMID: 19350320 DOI: 10.1007/s00268-009-9983-8] [Cited by in Crossref: 58] [Cited by in F6Publishing: 46] [Article Influence: 4.8] [Reference Citation Analysis]
42 Richards ML, Gauger P, Thompson NW, Giordano TJ. Regression of type II gastric carcinoids in multiple endocrine neoplasia type 1 patients with Zollinger-Ellison syndrome after surgical excision of all gastrinomas. World J Surg 2004;28:652-8. [PMID: 15383867 DOI: 10.1007/s00268-004-7345-0] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 2.2] [Reference Citation Analysis]
43 Asban A, Patel AJ, Reddy S, Wang T, Balentine CJ, Chen H. Cancer of the Endocrine System. Abeloff's Clinical Oncology. Elsevier; 2020. pp. 1074-1107.e11. [DOI: 10.1016/b978-0-323-47674-4.00068-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Kianmanesh R, O'toole D, Sauvanet A, Ruszniewski P, Belghiti J. [Surgical treatment of gastric, enteric, and pancreatic endocrine tumors Part 1. Treatment of primary endocrine tumors]. J Chir (Paris) 2005;142:132-49. [PMID: 16142076 DOI: 10.1016/s0021-7697(05)80881-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
45 Sadowski SM, Cadiot G, Dansin E, Goudet P, Triponez F. The future: surgical advances in MEN1 therapeutic approaches and management strategies. Endocr Relat Cancer 2017;24:T243-60. [PMID: 28811298 DOI: 10.1530/ERC-17-0285] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
46 Fendrich V, Langer P, Waldmann J, Bartsch DK, Rothmund M. Management of sporadic and multiple endocrine neoplasia type 1 gastrinomas. Br J Surg. 2007;94:1331-1341. [PMID: 17939142 DOI: 10.1002/bjs.5987] [Cited by in Crossref: 67] [Cited by in F6Publishing: 54] [Article Influence: 4.8] [Reference Citation Analysis]
47 Manoharan J, Waldmann J, Langer P, Bartsch DK. Inherited Pancreatic Endocrine Tumors. In: Neoptolemos JP, Urrutia R, Abbruzzese J, Büchler MW, editors. Pancreatic Cancer. New York: Springer; 2017. pp. 1-25. [DOI: 10.1007/978-1-4939-6631-8_25-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
48 Jensen RT. Carcinoid and pancreatic endocrine tumors: recent advances in molecular pathogenesis, localization, and treatment. Curr Opin Oncol. 2000;12:368-377. [PMID: 10888424 DOI: 10.1097/00001622-200007000-00015] [Cited by in Crossref: 60] [Cited by in F6Publishing: 54] [Article Influence: 2.9] [Reference Citation Analysis]
49 Norton JA. Surgery for primary pancreatic neuroendocrine tumors. J Gastrointest Surg 2006;10:327-31. [PMID: 16504877 DOI: 10.1016/j.gassur.2005.08.023] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 3.0] [Reference Citation Analysis]
50 Proye CA, Lokey JS. Current concepts in functioning endocrine tumors of the pancreas. World J Surg 2004;28:1231-8. [PMID: 15517477 DOI: 10.1007/s00268-004-7645-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
51 Imamura M, Komoto I, Ota S, Hiratsuka T, Kosugi S, Doi R, Awane M, Inoue N. Biochemically curative surgery for gastrinoma in multiple endocrine neoplasia type 1 patients. World J Gastroenterol 2011; 17(10): 1343-1353 [PMID: 21455335 DOI: 10.3748/wjg.v17.i10.1343] [Cited by in CrossRef: 69] [Cited by in F6Publishing: 46] [Article Influence: 6.9] [Reference Citation Analysis]
52 Geslot A, Vialon M, Caron P, Grunenwald S, Vezzosi D. New therapies for patients with multiple endocrine neoplasia type 1. Ann Endocrinol (Paris) 2021;82:112-20. [PMID: 33839123 DOI: 10.1016/j.ando.2021.03.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Akerström G, Hessman O, Hellman P, Skogseid B. Pancreatic tumours as part of the MEN-1 syndrome. Best Pract Res Clin Gastroenterol 2005;19:819-30. [PMID: 16253903 DOI: 10.1016/j.bpg.2005.05.006] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 3.0] [Reference Citation Analysis]
54 Gauger PG, Thompson NW. Early surgical intervention and strategy in patients with multiple endocrine neoplasia type 1. Best Pract Res Clin Endocrinol Metab 2001;15:213-23. [PMID: 11472035 DOI: 10.1053/beem.2001.0136] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.0] [Reference Citation Analysis]
55 Tonelli F, Giudici F, Nesi G, Batignani G, Brandi ML. Biliary tree gastrinomas in multiple endocrine neoplasia type 1 syndrome. World J Gastroenterol 2013; 19(45): 8312-8320 [PMID: 24363522 DOI: 10.3748/wjg.v19.i45.8312] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
56 Norton JA, Venzon DJ, Berna MJ, Alexander HR, Fraker DL, Libutti SK, Marx SJ, Gibril F, Jensen RT. Prospective study of surgery for primary hyperparathyroidism (HPT) in multiple endocrine neoplasia-type 1 and Zollinger-Ellison syndrome: Long-term outcome of a more virulent form of HPT. Ann Surg. 2008;247:501-510. [PMID: 18376196 DOI: 10.1097/sla.0b013e31815efda5] [Cited by in Crossref: 98] [Cited by in F6Publishing: 43] [Article Influence: 7.5] [Reference Citation Analysis]
57 Jensen RT. Pancreatic endocrine tumors: recent advances. Ann Oncol. 1999;10 Suppl 4:170-176. [PMID: 10436815 DOI: 10.1093/annonc/10.suppl_4.s170] [Cited by in Crossref: 42] [Cited by in F6Publishing: 2] [Article Influence: 1.9] [Reference Citation Analysis]
58 Hoffmann KM, Furukawa M, Jensen RT. Duodenal neuroendocrine tumors: Classification, functional syndromes, diagnosis and medical treatment. Best Pract Res Clin Gastroenterol. 2005;19:675-697. [PMID: 16253893 DOI: 10.1016/j.bpg.2005.05.009] [Cited by in Crossref: 109] [Cited by in F6Publishing: 90] [Article Influence: 7.3] [Reference Citation Analysis]
59 Giusti F, Marini F, Tonelli F, Brandi ML. Multiple endocrine neoplasia type 1. Principles of Bone Biology. Elsevier; 2020. pp. 1293-306. [DOI: 10.1016/b978-0-12-814841-9.00053-1] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
60 Tomassetti P, Salomone T, Migliori M, Campana D, Corinaldesi R. Optimal Treatment of Zollinger-Ellison Syndrome and Related Conditions in Elderly Patients: . Drugs & Aging 2003;20:1019-34. [DOI: 10.2165/00002512-200320140-00002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
61 Berna MJ, Hoffmann KM, Serrano J, Gibril F, Jensen RT. Serum gastrin in Zollinger-Ellison syndrome: I. Prospective study of fasting serum gastrin in 309 patients from the National Institutes of Health and comparison with 2229 cases from the literature. Medicine (Baltimore). 2006;85:295-330. [PMID: 17108778 DOI: 10.1097/01.md.0000236956.74128.76] [Cited by in Crossref: 138] [Cited by in F6Publishing: 108] [Article Influence: 9.2] [Reference Citation Analysis]
62 Kouvaraki MA, Shapiro SE, Cote GJ, Lee JE, Yao JC, Waguespack SG, Gagel RF, Evans DB, Perrier ND. Management of pancreatic endocrine tumors in multiple endocrine neoplasia type 1. World J Surg. 2006;30:643-653. [PMID: 16680581 DOI: 10.1007/s00268-006-0360-y] [Cited by in Crossref: 106] [Cited by in F6Publishing: 81] [Article Influence: 7.1] [Reference Citation Analysis]
63 Tomassetti P, Campana D, Piscitelli L, Mazzotta E, Brocchi E, Pezzilli R, Corinaldesi R. Treatment of Zollinger-Ellison Syndrome. World J Gastroenterol 2005; 11(35): 5423-5432 [PMID: 16222731 DOI: 10.3748/wjg.v11.i35.5423] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
64 Kouvaraki MA, Solorzano CC, Shapiro SE, Yao JC, Perrier ND, Lee JE, Evans DB. Surgical treatment of non-functioning pancreatic islet cell tumors. J Surg Oncol 2005;89:170-85. [PMID: 15719379 DOI: 10.1002/jso.20178] [Cited by in Crossref: 52] [Cited by in F6Publishing: 37] [Article Influence: 3.3] [Reference Citation Analysis]
65 Langer P, Rothmund M, Bartsch DK. Prophylaktische Chirurgie des Pankreas. Chirurg 2006;77:25-32. [DOI: 10.1007/s00104-005-1113-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
66 Akerström G, Stålberg P, Hellman P. Surgical management of pancreatico-duodenal tumors in multiple endocrine neoplasia syndrome type 1. Clinics (Sao Paulo) 2012;67 Suppl 1:173-8. [PMID: 22584725 DOI: 10.6061/clinics/2012(sup01)29] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
67 Hausman MS Jr, Thompson NW, Gauger PG, Doherty GM. The surgical management of MEN-1 pancreatoduodenal neuroendocrine disease. Surgery 2004;136:1205-11. [PMID: 15657577 DOI: 10.1016/j.surg.2004.06.049] [Cited by in Crossref: 51] [Cited by in F6Publishing: 41] [Article Influence: 3.2] [Reference Citation Analysis]
68 Al-Kurd A, Chapchay K, Grozinsky-Glasberg S, Mazeh H. Laparoscopic resection of pancreatic neuroendocrine tumors. World J Gastroenterol 2014; 20(17): 4908-4916 [PMID: 24803802 DOI: 10.3748/wjg.v20.i17.4908] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
69 Imamura M, Komoto I, Ota S. Changing treatment strategy for gastrinoma in patients with Zollinger-Ellison syndrome. World J Surg. 2006;30:1-11. [PMID: 16369713 DOI: 10.1007/s00268-005-0341-1] [Cited by in Crossref: 54] [Cited by in F6Publishing: 36] [Article Influence: 3.6] [Reference Citation Analysis]
70 Langer P, Wild A, Celik I, Kopp I, Bergenfelz A, Bartsch DK. Prospective controlled trial of a standardized meal stimulation test in the detection of pancreaticoduodenal endocrine tumours in patients with multiple endocrine neoplasia type 1. Br J Surg 2001;88:1403-7. [PMID: 11578300 DOI: 10.1046/j.0007-1323.2001.01874.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
71 Ellison EC, Johnson JA. The Zollinger-Ellison syndrome: a comprehensive review of historical, scientific, and clinical considerations. Curr Probl Surg. 2009;46:13-106. [PMID: 19059523 DOI: 10.1067/j.cpsurg.2008.09.001] [Cited by in Crossref: 58] [Cited by in F6Publishing: 42] [Article Influence: 4.8] [Reference Citation Analysis]
72 Norton JA. Surgical treatment and prognosis of gastrinoma. Best Pract Res Clin Gastroenterol 2005;19:799-805. [PMID: 16253901 DOI: 10.1016/j.bpg.2005.05.003] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
73 Norton JA, Jensen RT. Resolved and unresolved controversies in the surgical management of patients with Zollinger-Ellison syndrome. Ann Surg. 2004;240:757-773. [PMID: 15492556 DOI: 10.1097/01.sla.0000143252.02142.3e] [Cited by in Crossref: 166] [Cited by in F6Publishing: 140] [Article Influence: 9.8] [Reference Citation Analysis]
74 Yeung MJ, Pasieka JL. Gastrinomas: A historical perspective: Gastrinomas. J Surg Oncol 2009;100:425-33. [DOI: 10.1002/jso.21359] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
75 Hanazaki K, Sakurai A, Munekage M, Ichikawa K, Namikawa T, Okabayashi T, Imamura M. Surgery for a gastroenteropancreatic neuroendocrine tumor (GEPNET) in multiple endocrine neoplasia type 1. Surg Today. 2013;43:229-236. [PMID: 23076685 DOI: 10.1007/s00595-012-0376-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
76 Lopez CL, Falconi M, Waldmann J, Boninsegna L, Fendrich V, Goretzki PK, Langer P, Kann PH, Partelli S, Bartsch DK. Partial pancreaticoduodenectomy can provide cure for duodenal gastrinoma associated with multiple endocrine neoplasia type 1. Ann Surg. 2013;257:308-314. [PMID: 22580937 DOI: 10.1097/sla.0b013e3182536339] [Cited by in Crossref: 53] [Cited by in F6Publishing: 21] [Article Influence: 6.6] [Reference Citation Analysis]
77 Hoffmann KM, Gibril F, Entsuah LK, Serrano J, Jensen RT. Patients with multiple endocrine neoplasia type 1 with gastrinomas have an increased risk of severe esophageal disease including stricture and the premalignant condition, Barrett's esophagus. J Clin Endocrinol Metab 2006;91:204-12. [PMID: 16249283 DOI: 10.1210/jc.2005-1349] [Cited by in Crossref: 35] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
78 Truty MJ, Thompson GB. Surgical Treatment of Zollinger-Ellison Syndrome in Multiple Endocrine Neoplasia, Type 1. Mayo Clinic Proceedings 2005;80:1530. [DOI: 10.4065/80.11.1530] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
79 Lairmore TC, Chen H. Role of menin in neuroendocrine tumorigenesis. Adv Exp Med Biol 2009;668:87-95. [PMID: 20175456 DOI: 10.1007/978-1-4419-1664-8_9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
80 Tonelli F, Giudici F, Nesi G, Batignani G, Brandi ML. Operation for insulinomas in multiple endocrine neoplasia type 1: When pancreatoduodenectomy is appropriate. Surgery 2017;161:727-34. [PMID: 27863775 DOI: 10.1016/j.surg.2016.09.017] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
81 Callender GG, Rich TA, Perrier ND. Multiple endocrine neoplasia syndromes. Surg Clin North Am 2008;88:863-95, viii. [PMID: 18672144 DOI: 10.1016/j.suc.2008.05.001] [Cited by in Crossref: 51] [Cited by in F6Publishing: 30] [Article Influence: 3.9] [Reference Citation Analysis]
82 Li ML, Norton JA. Gastrinoma. Curr Treat Options in Oncol 2001;2:337-46. [DOI: 10.1007/s11864-001-0027-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
83 Ellison EC. Article Commentary: Zollinger–Ellison Syndrome: A Personal Perspective. The American Surgeon 2008;74:563-71. [DOI: 10.1177/000313480807400701] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
84 Albers MB, Manoharan J, Bartsch DK. Contemporary surgical management of the Zollinger-Ellison syndrome in multiple endocrine neoplasia type 1. Best Pract Res Clin Endocrinol Metab 2019;33:101318. [PMID: 31521501 DOI: 10.1016/j.beem.2019.101318] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
85 Imamura M, Komoto I. Gastrinoma. In: Hubbard J, Inabnet WB, Lo C, editors. Endocrine Surgery. London: Springer; 2009. pp. 507-21. [DOI: 10.1007/978-1-84628-881-4_38] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
86 Gibril F, Schumann M, Pace A, Jensen RT. Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: a prospective study of 107 cases and comparison with 1009 cases from the literature. Medicine (Baltimore). 2004;83:43-83. [PMID: 14747767 DOI: 10.1097/01.md.0000112297.72510.32] [Cited by in Crossref: 213] [Cited by in F6Publishing: 172] [Article Influence: 12.5] [Reference Citation Analysis]
87 Hung PD, Schubert ML, Mihas AA. Zollinger-Ellison syndrome. Curr Treat Options Gastro 2003;6:163-70. [DOI: 10.1007/s11938-003-0017-6] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
88 Imamura M, Nakamoto Y, Uose S, Komoto I, Awane M, Taki Y. Diagnosis of functioning pancreaticoduodenal neuroendocrine tumors. J Hepatobiliary Pancreat Sci 2015;22:602-9. [PMID: 25624017 DOI: 10.1002/jhbp.209] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
89 Partelli S, Maurizi A, Tamburrino D, Baldoni A, Polenta V, Crippa S, Falconi M. GEP-NETS update: a review on surgery of gastro-entero-pancreatic neuroendocrine tumors. Eur J Endocrinol. 2014;171:R153-R162. [PMID: 24920289 DOI: 10.1530/eje-14-0173] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
90 Marx SJ. Multiple Endocrine Neoplasia Type 1. The Parathyroids. Elsevier; 2001. pp. 535-84. [DOI: 10.1016/b978-012098651-4/50037-7] [Cited by in Crossref: 9] [Article Influence: 0.5] [Reference Citation Analysis]
91 Dotzenrath C, Goretzki PE, Cupisti K, Yang Q, Simon D, Röher H. Malignant endocrine tumors in patients with MEN 1 disease. Surgery 2001;129:91-5. [DOI: 10.1067/msy.2001.109500] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
92 Norton JA, Alexander HR, Fraker DL, Venzon DJ, Gibril F, Jensen RT. Comparison of surgical results in patients with advanced and limited disease with multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome. Ann Surg. 2001;234:495-505; discussion 505-6. [PMID: 11573043 DOI: 10.1097/00000658-200110000-00009] [Cited by in Crossref: 150] [Cited by in F6Publishing: 126] [Article Influence: 7.5] [Reference Citation Analysis]
93 Lopez CL, Waldmann J, Fendrich V, Langer P, Kann PH, Bartsch DK. Long-term results of surgery for pancreatic neuroendocrine neoplasms in patients with MEN1. Langenbecks Arch Surg 2011;396:1187-96. [PMID: 21805182 DOI: 10.1007/s00423-011-0828-1] [Cited by in Crossref: 50] [Cited by in F6Publishing: 39] [Article Influence: 5.0] [Reference Citation Analysis]